The DOI matches its Crossref record; 515 of the 515 references it cites were found in a registry or an index.
Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Abstract
The neurohypophysial hormone arginine vasopressin (AVP) is essential for a wide range of physiological functions, including water reabsorption, cardiovascular homeostasis, hormone secretion, and social behavior. These and other actions of AVP are mediated by at least three distinct receptor subtypes: V1a, V1b, and V2. Although the antidiuretic action of AVP and V2 receptor in renal distal tubules and collecting ducts is relatively well understood, recent years have seen an increasing understanding of the physiological roles of V1a and V1b receptors. The V1a receptor is originally found in the vascular smooth muscle and the V1b receptor in the anterior pituitary. Deletion of V1a or V1b receptor genes in mice revealed that the contributions of these receptors extend far beyond cardiovascular or hormone-secreting functions. Together with extensively developed pharmacological tools, genetically altered rodent models have advanced the understanding of a variety of AVP systems. Our report reviews the findings in this important field by covering a wide range of research, from the molecular physiology of V1a and V1b receptors to studies on whole animals, including gene knockout/knockdown studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,862
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
The mouse brain in stereotaxic coordinates
Konsman, J.-P. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00088-x · Cited by 4,045
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
VALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
The oxytocin receptor system: structure, function, and regulation
Gimpl, G., & Fahrenholz, F. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.629 · Cited by 3,089
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Dopamine in schizophrenia: a review and reconceptualization
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1474 · Cited by 2,018
Crystal structure of the human β2 adrenergic G-protein-coupled receptor
Rasmussen, S. G. F., Choi, H.-J., Rosenbaum, D. M., Kobilka, T. S., Thian, F. S., Edwards, P. C., Burghammer, M., Ratnala, V. R. P., Sanishvili, R., Fischetti, R. F., et al. (2007) · Nature · doi:10.1038/nature06325 · Cited by 1,930
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067373 · Cited by 1,924
Ferguson, S. S. G. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01478-9 · Cited by 1,826
Jares-Erijman, E. A., & Jovin, T. M. (2003) · Nature Biotechnology · doi:10.1038/nbt896 · Cited by 1,824
Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688
Oxytocin, vasopressin, and the neurogenetics of sociality
Donaldson, Z. R., & Young, L. J. (2008) · Science · doi:10.1126/science.1158668 · Cited by 1,645
Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484
Sniffing neuropeptides: A transnasal approach to the human brain
Born, J., Lange, T., Kern, W., McGregor, G. P., Bickel, U., & Fehm, H. L. (2002) · Nature Neuroscience · doi:10.1038/nn0602-849 · Cited by 1,356
Intracellular ATP directly blocks K+ channels in pancreatic B-cells
Cook, D. L., & Hales, N. (1984) · Nature · doi:10.1038/311271a0 · Cited by 1,208 · cited 1×
“Also, AVP was previously reported to facilitate the closure of the ATP-sensitive potassium channel, a critical regulator of the plasma membrane potential (97, 324).”
BackgroundDisruption of Adiponectin Causes Insulin Resistance and Neointimal Formation
Kubota, N., Terauchi, Y., Yamauchi, T., Kubota, T., Moroi, M., Matsui, J., Eto, K., Yamashita, T., Kamon, J., Satoh, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200251200 · Cited by 1,208
Sawchenko, P. E., & Swanson, L. W. (1982) · Journal of Comparative Neurology · doi:10.1002/cne.902050306 · Cited by 1,150
Disruption of adiponectin causes insulin resistance and neointimal formation
Froguel, P. (2002) · HAL · Cited by 1,126
Swerdlow, N., Geyer, M., & Braff, D. (2001) · Psychopharmacology · doi:10.1007/s002130100799 · Cited by 1,050
Gating and Habituation of the Startle Reflex in Schizophrenic Patients
Braff, D. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820030038005 · Cited by 1,027
Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock
Landry, D. W., Levin, H. R., Gallant, E. M., Ashton, R. C., Seo, S., D'Alessandro, D., Oz, M. C., & Oliver, J. A. (1997) · Circulation · doi:10.1161/01.cir.95.5.1122 · Cited by 990
Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
Gillies, G. E., Linton, E. A., & Lowry, P. J. (1982) · Nature · doi:10.1038/299355a0 · Cited by 965
A Molecular Mechanism Regulating Rhythmic Output from the Suprachiasmatic Circadian Clock
Jin, X., Shearman, L. P., Weaver, D. R., Zylka, M. J., De Vries, G. J., & Reppert, S. M. (1999) · Cell · doi:10.1016/s0092-8674(00)80959-9 · Cited by 903
ANTONI, F. A. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-4-351 · Cited by 883
Synthesis, transport, and release of posterior pituitary hormones
Brownstein, M. J., Russell, J. T., & Gainer, H. (1980) · Science · doi:10.1126/science.6153132 · Cited by 838
Teaching old receptors new tricks: biasing seven-transmembrane receptors
Rajagopal, S., Rajagopal, K., & Lefkowitz, R. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3024 · Cited by 825
Robertson, G. L., Mahr, E. A., Athar, S., & Sinha, T. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107423 · Cited by 787
Roles of G‐protein‐coupled receptor dimerization: From ontogeny to signalling regulation
Terrillon, S., & Bouvier, M. (2004) · EMBO reports · doi:10.1038/sj.embor.7400052 · Cited by 683
Oligomerization of G-protein-coupled transmitter receptors
Bouvier, M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35067575 · Cited by 669
GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling
Reiter, E., & Lefkowitz, R. J. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.03.008 · Cited by 666
Sanyal, A. J., Boyer, T., Garcia–Tsao, G., Regenstein, F., Rossaro, L., Appenrodt, B., Blei, A., Gülberg, V., Sigal, S., & Teuber, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.014 · Cited by 663
A Comparison of Vasopressin and Epinephrine for Out-of-Hospital Cardiopulmonary Resuscitation
Wenzel, V., Krismer, A. C., Arntz, H. R., Sitter, H., Stadlbauer, K. H., & Lindner, K. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa025431 · Cited by 643
Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age
Antoni, F. A. (1993) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1993.1004 · Cited by 636
Goodson, J. L., & Bass, A. H. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00043-1 · Cited by 636
Structure and expression of a human oxytocin receptor
Kimura, T., Tanizawa, O., Mori, K., Brownstein, M. J., & Okayama, H. (1992) · Nature · doi:10.1038/356526a0 · Cited by 632
Lim, M. M., Wang, Z., Olazábal, D. E., Ren, X., Terwilliger, E. F., & Young, L. J. (2004) · Nature · doi:10.1038/nature02539 · Cited by 628
Glutamatergic mechanisms in schizophrenia
Tsai, G., & Coyle, J. T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082701.160735 · Cited by 577
Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor
Land, H., Schütz, G., Schmale, H., & Richter, D. (1982) · Nature · doi:10.1038/295299a0 · Cited by 569
Oakley, R. H., Laporte, S. A., Holt, J. A., Barak, L. S., & Caron, M. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32248 · Cited by 567
Morello, J.-P., Salahpour, A., Laperrière, A., Bernier, V., Arthus, M.-F., Lonergan, M., Petäjä-Repo, U., Angers, S., Morin, D., Bichet, D. G., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8688 · Cited by 565
Molecular cloning of the receptor for human antidiuretic hormone
Birnbaumer, M., Seibold, A., Gilbert, S., Ishido, M., Barberis, C., Antaramian, A., Brabet, P., & Rosenthal, W. (1992) · Nature · doi:10.1038/357333a0 · Cited by 546
Bielsky, I. F., Hu, S.-B., Szegda, K. L., Westphal, H., & Young, L. J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300360 · Cited by 531
Lolait, S. J., O'Carroll, A.-M., McBride, O. W., Konig, M., Morel, A., & Brownstein, M. J. (1992) · Nature · doi:10.1038/357336a0 · Cited by 524 · cited 1×
“The V2 receptor is found in the renal distal tubules and collecting ducts, and stimulates water absorption (52, 312).”
BackgroundMaurel, D., Comps-Agrar, L., Brock, C., Rives, M.-L., Bourrier, E., Ayoub, M. A., Bazin, H., Tinel, N., Durroux, T., Prézeau, L., et al. (2008) · Nature Methods · doi:10.1038/nmeth.1213 · Cited by 505
Diagnosis and management of dysmenorrhoea
Proctor, M., & Farquhar, C. (2006) · BMJ · doi:10.1136/bmj.332.7550.1134 · Cited by 505
Vasopressin: Behavioral roles of an “original” neuropeptide
Caldwell, H. K., Lee, H.-J., Macbeth, A. H., & Young, W. S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.10.007 · Cited by 504
Ferris, C. F., Melloni Jr, R. H., Koppel, G., Perry, K. W., Fuller, R. W., & Delville, Y. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04331.1997 · Cited by 495
Young, L. J., Nilsen, R., Waymire, K. G., MacGregor, G. R., & Insel, T. R. (1999) · Nature · doi:10.1038/23475 · Cited by 488
Molecular cloning and expression of a rat Via arginine vasopressin receptor
Morel, A., O'Carroll, A.-M., Brownstein, M. J., & Lolaft, S. J. (1992) · Nature · doi:10.1038/356523a0 · Cited by 477
Griebel, G., Simiand, J., Serradeil-Le Gal, C., Wagnon, J., Pascal, M., Scatton, B., Maffrand, J.-P., & Soubrié, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092012099 · Cited by 471
The Aquaporins, Blueprints for Cellular Plumbing Systems
Agre, P., Bonhivers, M., & Borgnia, M. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.14659 · Cited by 463
Walum, H., Westberg, L., Henningsson, S., Neiderhiser, J. M., Reiss, D., Igl, W., Ganiban, J. M., Spotts, E. L., Pedersen, N. L., Eriksson, E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803081105 · Cited by 460
Insel, T., Wang, Z., & Ferris, C. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-09-05381.1994 · Cited by 454
Principles of Neuropsychopharmacology
Feldman, R. S., Meyer, J. S., & Quenzer, L. F. (1997) · Cited by 444
Nephrogenic Diabetes Insipidus
Morello, J.-P., & Bichet, D. G. (2001) · Annual Review of Physiology · doi:10.1146/annurev.physiol.63.1.607 · Cited by 443
Purba, J. S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830020055007 · Cited by 433
Sex differences in oxytocin and vasopressin: Implications for autism spectrum disorders?
CARTER, C. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.08.025 · Cited by 432
Modulation of social memory in male rats by neurohypophyseal peptides
Dantzer, R., Bluthe, R. M., Koob, G. F., & Le Moal, M. (1987) · Psychopharmacology · doi:10.1007/bf00518192 · Cited by 423
Vasopressin and oxytocin receptors in the central nervous system
Tribollet, E., & Barberis, C. (1996) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v10.i1.60 · Cited by 399 · cited 1×
“The abundantly expressed receptors for AVP in the brain are the V1a and OT receptor subtypes (255, 511); no V2 receptor-specific ligand binding or V2 receptor mRNA has been reported (41, 157), with the exception of an autoregulatory V2 receptor in the AVP neurons (440).”
BackgroundVasopressin V1b receptor knockout reduces aggressive behavior in male mice
Wersinger, S. R., Ginns, E. I., O'Carroll, A.-M., Lolait, S. J., & Young III, W. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001195 · Cited by 397
Ntau-methylhistidine (3-methylhistidine) and muscle protein turnover: an overview.
Young, V. R., & Munro, H. N. (1978) · PubMed · Cited by 395
Vasopressin pressor hypersensitivity in vasodilatory septic shock
Landry, D. W., Levin, H. R., Gallant, E. M., Seo, S., D'Alessandro, D., Oz, M. C., & Oliver, J. A. (1997) · Critical Care Medicine · doi:10.1097/00003246-199708000-00012 · Cited by 390
Young (1999) · doi:10.1038/23650 · Cited by 389
Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor.
Sugimoto, T., Saito, M., Mochizuki, S., Watanabe, Y., Hashimoto, S., & Kawashima, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47129-3 · Cited by 378
Non-peptide arginine-vasopressin antagonists: the vaptans
Decaux, G., Soupart, A., & Vassart, G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60695-9 · Cited by 376
Aguilera, G., & Rabadan-Diehl, C. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00196-8 · Cited by 375
Oliver, G., & Schäfer, E. A. (1895) · The Journal of Physiology · doi:10.1113/jphysiol.1895.sp000565 · Cited by 370
Bielsky, I. F., Hu, S.-B., Ren, X., Terwilliger, E. F., & Young, L. J. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.031 · Cited by 367
Direct effects of leptin on brown and white adipose tissue.
Siegrist-Kaiser, C. A., Pauli, V, Juge-Aubry, C. E., Boss, O., Pernin, A., Chin, W. W., Cusin, I., Rohner-Jeanrenaud, F., Burger, A. G., Zapf, J., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119834 · Cited by 366
Hauger, R. L., Grigoriadis, D. E., Dallman, M. F., Plotsky, P. M., Vale, W. W., & Dautzenberg, F. M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.3 · Cited by 365
Novel Form of Lipolysis Induced by Leptin
Wang, M.-Y., Lee, Y., & Unger, R. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17541 · Cited by 364
Science review: Vasopressin and the cardiovascular system part 1--receptor physiology.
(2003) · Critical Care · doi:10.1186/cc2337 · Cited by 356
Ectopic and Abnormal Hormone Receptors in Adrenal Cushing’s Syndrome*
Lacroix, A., N′Diaye, N., Tremblay, J., & Hamet, P. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.1.0420 · Cited by 350
Hauger, R., Risbrough, V., Brauns, O., & Dautzenberg, F. (2006) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152706777950684 · Cited by 343
Birnbaumer, M. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00304-0 · Cited by 342
Time-resolved FRET between GPCR ligands reveals oligomers in native tissues
Albizu, L., Cottet, M., Kralikova, M., Stoev, S., Seyer, R., Brabet, I., Roux, T., Bazin, H., Bourrier, E., Lamarque, L., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.396 · Cited by 340
Phorbol esters and vasopressin stimulate DNA synthesis by a common mechanism
Dicker, P., & Rozengurt, E. (1980) · Nature · doi:10.1038/287607a0 · Cited by 329
Central Nervous System Effects of the Neurohypophyseal Hormones and Related Peptides
de Wied, D., Diamant, M., & Fodor, M. (1993) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1993.1009 · Cited by 327
Terrillon, S., Durroux, T., Mouillac, B., Breit, A., Ayoub, M. A., Taulan, M., Jockers, R., Barberis, C., & Bouvier, M. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0222 · Cited by 322
Alonso, R., Griebel, G., Pavone, G., Stemmelin, J., Le Fur, G., & Soubrié, P. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001464 · Cited by 319
The Vasopressin System: Physiology and Clinical Strategies
Treschan, T. A., Peters, J., & Warltier, D. C. (2006) · Anesthesiology · doi:10.1097/00000542-200609000-00026 · Cited by 316
Sex-specific influences of vasopressin on human social communication
Thompson, R. R., George, K., Walton, J. C., Orr, S. P., & Benson, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600406103 · Cited by 312
Information-processing deficits and thought disorder in schizophrenia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.3.363 · Cited by 309
Plasma Levels of Arginine Vasopressin Elevated in Patients with Major Depression
van Londen, L. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00054-7 · Cited by 306
Role of vasopressin in cardiovascular regulation.
Share, L. (1988) · Physiological Reviews · doi:10.1152/physrev.1988.68.4.1248 · Cited by 301
COWLEY, A. W., MONOS, E., & GUYTON, A. C. (1974) · Circulation Research · doi:10.1161/01.res.34.4.505 · Cited by 299
MANNING, M., STOEV, S., CHINI, B., DURROUX, T., MOUILLAC, B., & GUILLON, G. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00437-8 · Cited by 296
Tomita, K., Pisano, J. J., & Knepper, M. A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111935 · Cited by 295
Oxytocin receptor-deficient mice developed late-onset obesity
Takayanagi, Y., Kasahara, Y., Onaka, T., Takahashi, N., Kawada, T., & Nishimori, K. (2008) · Neuroreport · doi:10.1097/wnr.0b013e3283021ca9 · Cited by 294
Prevention of Preterm Delivery
Simhan, H. N., & Caritis, S. N. (2007) · New England Journal of Medicine · doi:10.1056/nejmra050435 · Cited by 292
Broekkamp, C. L., Rijk, H. W., Joly-Gelouin, D., & Lloyd, K. L. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90051-8 · Cited by 286
What's wrong with my mouse model?
Kalueff, A. V., Wheaton, M., & Murphy, D. L. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.01.023 · Cited by 285
Brain vasopressin is an important regulator of maternal behavior independent of dams’ trait anxiety
Bosch, O. J., & Neumann, I. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807412105 · Cited by 280
Jard, S., Gaillard, R. C., Guillon, G., Marie, J., Schoenenberg, P., Muller, A. F., Manning, M., & Sawyer, W. H. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10336-2 · Cited by 276
Hernando, F. (2001) · Endocrinology · doi:10.1210/en.142.4.1659 · Cited by 275
Aguilera, G., Harwood, J. P., Wilson, J. X., Morell, J., Brown, J. H., & Catt, K. J. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82024-9 · Cited by 273
Montani, J. P., Liard, J. F., Schoun, J., & Möhring, J. (1980) · Circulation Research · doi:10.1161/01.res.47.3.346 · Cited by 272
Reflex control of magnocellular vasopressin and oxytocin secretion
Cunningham, E. T., & Sawchenko, P. E. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90032-p · Cited by 266
Kim, S.-J., Young, L. J., Gonen, D., Veenstra-VanderWeele, J., Courchesne, R., Courchesne, E., Lord, C., Leventhal, B. L., Cook Jr, E. H., & Insel, T. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001125 · Cited by 265
The Binding Site of Neuropeptide Vasopressin V1a Receptor
Mouillac, B., Chini, B., Balestre, M.-N., Elands, J., Trumpp-Kallmeyer, S., Hoflack, J., Hibert, M., Jard, S., & Barberis, C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25771 · Cited by 262
Allostery at G Protein-Coupled Receptor Homo- and Heteromers: Uncharted Pharmacological Landscapes
Smith, N. J., & Milligan, G. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002667 · Cited by 262
Nonapeptide mechanisms of social cognition, behavior and species-specific social systems
Goodson, J. L., & Thompson, R. R. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.08.020 · Cited by 261
Vasopressin receptor blockade in the anterior hypothalamus suppresses aggression in hamsters
Ferris, C. F., & Potegal, M. (1988) · Physiology & Behavior · doi:10.1016/0031-9384(88)90144-8 · Cited by 259
Tanoue, A., Ito, S., Honda, K., Oshikawa, S., Kitagawa, Y., Koshimizu, T., Mori, T., & Tsujimoto, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19656 · Cited by 258
Self-citationMolecular Biology of Hereditary Diabetes Insipidus
Fujiwara, T. M., & Bichet, D. G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040371 · Cited by 252
de Goeij, D. C. E., Kvetnansky, R., Whitnall, M. H., Jezova, D., Berkenbosch, F., & Tilders, F. J. H. (2008) · Neuroendocrinology · doi:10.1159/000125712 · Cited by 250 · cited 1×
“Chronic stress such as repeated restraint increased AVP transcription in the parvocellular neurons and immunoreactive AVP signals in the rat median eminence, whereas CRH transcription increased only transiently upon the initial stress, while CRH immunopositive signals did not change even though corticosterone response…”
BackgroundWang, S.-S., Kamphuis, W., Huitinga, I., Zhou, J.-N., & Swaab, D. F. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.38 · Cited by 250
Pharmacologic Chaperones as a Potential Treatment for X-Linked Nephrogenic Diabetes Insipidus
Bernier, V., Morello, J.-P., Zarruk, A., Debrand, N., Salahpour, A., Lonergan, M., Arthus, M.-F. C., Laperrière, A., Brouard, R., Bouvier, M., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080854 · Cited by 248
The effects of vasopressin on acute kidney injury in septic shock
Gordon, A. C., Russell, J. A., Walley, K. R., Singer, J., Ayers, D., Storms, M. M., Holmes, C. L., Hébert, P. C., Cooper, D. J., Mehta, S., et al. (2010) · Intensive Care Medicine · doi:10.1007/s00134-009-1687-x · Cited by 244
Kalsbeek, A., La Fleur, S., Van Heijningen, C., & Buijs, R. M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5328-03.2004 · Cited by 244
Conn, P. M., Ulloa-Aguirre, A., Ito, J., & Janovick, J. A. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.3.2 · Cited by 243
Vasopressin causes endothelium-dependent relaxations of the canine basilar artery.
Katusic, Z. S., Shepherd, J. T., & Vanhoutte, P. M. (1984) · Circulation Research · doi:10.1161/01.res.55.5.575 · Cited by 242
The Worldwide Atosiban versus Beta‐agonists Study Group Participants are listed in (2001) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2001.00043.x · Cited by 237
Obese Gene Expression Alters the Ability of 30A5 Preadipocytes to Respond to Lipogenic Hormones
Bai, Y., Zhang, S., Kim, K.-S., Lee, J.-K., & Kim, K.-H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.13939 · Cited by 237
Engler, D., Pham, T., Fullerton, M. J., Ooi, G., Funder, J. W., & Clarke, I. J. (2008) · Neuroendocrinology · doi:10.1159/000125141 · Cited by 235
Low sympathetic tone and obese phenotype in oxytocin-deficient mice
Camerino, C. (2009) · Obesity · doi:10.1038/oby.2009.12 · Cited by 235 · cited 1×
“Brattleboro rats have an increased level of plasma OT, which acts to regulate glucose tolerance as well as energy homeostasis (84, 481).”
BackgroundEngelmann, M., & Landgraf, R. (1994) · Physiology & Behavior · doi:10.1016/0031-9384(94)90022-1 · Cited by 225
Young, W. S., Li, J., Wersinger, S. R., & Palkovits, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.040 · Cited by 222
Meyer-Lindenberg, A., Kolachana, B., Gold, B., Olsh, A., Nicodemus, K. K., Mattay, V, Dean, M., & Weinberger, D. R. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.54 · Cited by 221
Testosterone facilitates aggression by modulating vasopressin receptors in the hypothalamus
Delville, Y., Mansour, K. M., & Ferris, C. F. (1996) · Physiology & Behavior · doi:10.1016/0031-9384(95)02246-5 · Cited by 221
Morelli, A., Ertmer, C., Rehberg, S., Lange, M., Orecchioni, A., Cecchini, V., Bachetoni, A., D'Alessandro, M., Van Aken, H., Pietropaoli, P., et al. (2009) · Critical Care · doi:10.1186/cc7990 · Cited by 221
An intrinsic vasopressin system in the olfactory bulb is involved in social recognition
Tobin, V. A., Hashimoto, H., Wacker, D. W., Takayanagi, Y., Langnaese, K., Caquineau, C., Noack, J., Landgraf, R., Onaka, T., Leng, G., et al. (2010) · Nature · doi:10.1038/nature08826 · Cited by 213
Pharmacology and clinical perspectives of vasopressin antagonists.
László, F. A., László, F., & De Wied, D. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06661-x · Cited by 213
Arginine Vasopressin Induces Endothelium-dependent Vasodilatation of the Pulmonary Artery
Evora, P. R. B., Pearson, P. J., & Schaff, H. V. (1993) · Chest · doi:10.1378/chest.103.4.1241 · Cited by 213
Paracrine control of adrenal cortical function by medullary chromaffin cells
Nussdorfer, G. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06956-x · Cited by 212
Gal, C. S.-L., Wagnon, J., Simiand, J., Griebel, G., Lacour, C., Guillon, G., Barberis, C., Brossard, G., Soubrié, P., Nisato, D., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.1122 · Cited by 211
Vasopressin stimulation of mouse 3T3 cell growth.
Rozengurt, E., Legg, A., & Pettican, P. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.3.1284 · Cited by 210
The Hypothalamus and Hypertension
De Wardener, H. E. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.4.1599 · Cited by 205
Science Review: Vasopressin and the cardiovascular system part 2 - clinical physiology.
Holmes, C. L., Landry, D. W., & Granton, J. T. (2003) · Critical Care · doi:10.1186/cc2338 · Cited by 203
Vasopressin Exhibits a Rhythmic Daily Pattern in Cerebrospinal Fluid But Not in Blood
Reppert, S. M., Artman, H. G., Swaminathan, S., & Fisher, D. A. (1981) · Science · doi:10.1126/science.7268432 · Cited by 201
Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex
Ellenbroek, B. A., Budde, S., & Cools, A. R. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00307-7 · Cited by 197
Corticotropin Releasing Hormone, Receptor Regulation and the Stress Response
Aguilera, G. (1998) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(98)00079-4 · Cited by 195
Egashira, N., Tanoue, A., Matsuda, T., Koushi, E., Harada, S., Takano, Y., Tsujimoto, G., Mishima, K., Iwasaki, K., & Fujiwara, M. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.12.009 · Cited by 193
Self-citationTerlipressin in acute oesophageal variceal haemorrhage
Ioannou, G. N., Doust, J., & Rockey, D. C. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01356.x · Cited by 185
G-protein-coupled receptors and islet function—Implications for treatment of type 2 diabetes
Winzell, M. S., & Ahrén, B. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.08.002 · Cited by 183
Structural insights into adrenergic receptor function and pharmacology
Kobilka, B. K. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.02.005 · Cited by 181
The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human
Goodwin, T. M., Paul, R., Silver, H., Spellacy, W., Parsons, M., Chez, R., Hayashi, R., Valenzuela, G., Creasy, G. W., & Merriman, R. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70214-4 · Cited by 180
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor
Chini, B., Mouillac, B., Ala, Y., Balestre, M. N., Trumpp‐Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M., Manning, M., & Jard, S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07211.x · Cited by 179
Selective impairments in the stress response in schizophrenic patients
Jansen, L. M. C., Gispen-de Wied, C. C., & Kahn, R. S. (2000) · Psychopharmacology · doi:10.1007/s002130000381 · Cited by 179
Neural Circuitry in the Regulation of Adrenal Corticosterone Rhythmicity
Engeland, W. C., & Arnhold, M. M. (2005) · Endocrine · doi:10.1385/endo:28:3:325 · Cited by 178
Koshimizu, T.-A., Nasa, Y., Tanoue, A., Oikawa, R., Kawahara, Y., Kiyono, Y., Adachi, T., Tanaka, T., Kuwaki, T., Mori, T., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600875103 · Cited by 178
Self-citationCorticotrophin releasing factor may be modulated vasopressin
GILLIES, G., & LOWRY, P. (1979) · Nature · doi:10.1038/278463a0 · Cited by 174
The agouti gene product inhibits lipolysis in human adipocytes via a Ca 2+ ‐dependent mechanism
Xue, B., Moustaid‐Moussa, N., Wilkison, W. O., & Zemel, M. B. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.13.1391 · Cited by 172
Lipolysis and the integrated physiology of lipid energy metabolism
Wang, S., Soni, K. G., Semache, M., Casavant, S., Fortier, M., Pan, L., & Mitchell, G. A. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.06.012 · Cited by 171
Ma, X.-M., Levy, A., & Lightman, S. L. (1997) · Endocrinology · doi:10.1210/endo.138.10.5446 · Cited by 171
Kumari, V., & Sharma, T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1099-x · Cited by 170
CENTRAL EFFECTS OF ARGININE VASOPRESSIN ON BLOOD PRESSURE IN RATS
PITTMAN, Q. J., LAWRENCE, D., & McLEAN, L. (1982) · Endocrinology · doi:10.1210/endo-110-3-1058 · Cited by 169
Landgraf, R., Frank, E., Aldag, J. M., Neumann, I. D., Sharer, C. A., Ren, X., Terwilliger, E. F., Niwa, M., Wigger, A., & Young, L. J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02750.x · Cited by 164
The vasopressin system — From antidiuresis to psychopathology
Frank, E., & Landgraf, R. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.063 · Cited by 162
Ophir, A. G., Wolff, J. O., & Phelps, S. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709116105 · Cited by 160
Freeman, J. G., Lishman, A. H., Cobden, I., & Record, C. O. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91689-0 · Cited by 160
Fatherhood affects dendritic spines and vasopressin V1a receptors in the primate prefrontal cortex
Kozorovitskiy, Y., Hughes, M., Lee, K., & Gould, E. (2006) · Nature Neuroscience · doi:10.1038/nn1753 · Cited by 158
Terrillon, S., Barberis, C., & Bouvier, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305322101 · Cited by 158
Ostrowski, N. L., Young, W. S., Knepper, M. A., & Lolait, S. J. (1993) · Endocrinology · doi:10.1210/endo.133.4.8404628 · Cited by 154
Carnitine acyltransferases and their influence on CoA pools in health and disease
RAMSAY, R. (2004) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.06.002 · Cited by 153
Aguilera, G., Subburaju, S., YOUNG, S., & CHEN, J. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00403-2 · Cited by 152
Innamorati, G., Gouill, C. L., Balamotis, M. A., & Birnbaumer, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009780200 · Cited by 151
Maintenance treatment of preterm labor with the oxytocin antagonist atosiban
Valenzuela, G. J., Sanchez‐Ramos, L., Romero, R. J., Silver, H. M., Koltun, W. D., Millar, L. K., Hobbins, J. C., Rayburn, W. F., Shangold, G. A., Wang, J., et al. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.105816 · Cited by 151
Stimulation by vasopressin of glycogen breakdown and gluconeogenesis in the perfused rat liver
Hems, D. A., & Whitton, P. D. (1973) · Biochemical Journal · doi:10.1042/bj1360705 · Cited by 150
Aquaporins in kidney pathophysiology
Noda, Y., Sohara, E., Ohta, E., & Sasaki, S. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.231 · Cited by 150
Lolait, S. J., Stewart, L. Q., Jessop, D. S., Young, W. S., & O’Carroll, A. (2006) · Endocrinology · doi:10.1210/en.2006-1309 · Cited by 150
Cerebrospinal Fluid Neurochemistry in Children and Adolescents With Obsessive-Compulsive Disorder
Swedo, S. E., Leonard, H. L., Kruesi, M. J., Rettew, D. C., Listwak, S. J., Berrettini, W., Stipetic, M., Hamburger, S., Gold, P. W., & Potter, W. Z. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820010029004 · Cited by 149
Vasopressin 1b Receptor Knock-Out Impairs Memory for Temporal Order
DeVito, L. M., Konigsberg, R., Lykken, C., Sauvage, M., Young, W. S., & Eichenbaum, H. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5488-08.2009 · Cited by 147
Li, J., Burton, K. J., Zhang, C., Hu, S.-B., & Zhou, Q. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90463.2008 · Cited by 146
The Basic and Clinical Pharmacology of Nonpeptide Vasopressin Receptor Antagonists
Thibonnier, M., Coles, P., Thibonnier, A., & Shoham, M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.175 · Cited by 146
Vasopressin 1a receptor knockout mice have a subtle olfactory deficit but normal aggression
Wersinger, S. R., Caldwell, H. K., Martinez, L. A., Gold, P. W., Hu, S.-B., & Young, W. S. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00281.x · Cited by 145
Molecular Pharmacology of Human Vasopressin Receptors
Thibonnier, M., Conarty, D. M., Preston, J. A., Wilkins, P. L., Berti‐Mattera, L. N., & Mattera, R. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4871-3_34 · Cited by 144
Amelioration of Metabolic Acidosis with Fludrocortisone Therapy in Hyporeninemic Hypoaldosteronism
Sebastián, A., Schambelan, M., Lindenfeild, S., & Morris, R. C. (1977) · New England Journal of Medicine · doi:10.1056/nejm197709152971104 · Cited by 143
Relationship between acid-soluble carnitine and coenzyme A pools in vivo
Brass, E. P., & Hoppel, C. L. (1980) · Biochemical Journal · doi:10.1042/bj1900495 · Cited by 141
Vasopressin released within the central amygdala promotes maternal aggression
Bosch, O. J., & Neumann, I. D. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07115.x · Cited by 141
G-protein-coupled receptor heterodimers: pharmacology, function and relevance to drug discovery
Milligan, G. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.04.007 · Cited by 139
Thibonnier, M., Preston, J. A., Dulin, N. O., Wilkins, P. L., Berti‐Mattera, L. N., & Mattera, R. (1997) · Endocrinology · doi:10.1210/endo.138.10.5432 · Cited by 138
Vasopressin dependent adenylate cyclase in single segments of rabbit kidney tubule
Imbert–Teboul, M., Chabard�s, D., Montégut, M., Clique, A., & Morel, F. (1975) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00585973 · Cited by 136
McCann, S. M., & Brobeck, J. R. (1954) · Experimental Biology and Medicine · doi:10.3181/00379727-87-21368 · Cited by 136
The neurohypophysial endocrine regulatory cascade: precursors, mediators, receptors, and effectors
Acher, R., & Chauvet, J. (1995) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1995.1009 · Cited by 135
Terada, Y., Tomita, K., Nonoguchi, H., Yang, T., & Marumo, F. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116838 · Cited by 135
Self-citationVasopressin innervation of the mouse ( Mus musculus ) brain and spinal cord
Rood, B. D., & De Vries, G. J. (2011) · Journal of Comparative Neurology · doi:10.1002/cne.22635 · Cited by 134
Receptor heteromerization and drug discovery
Rozenfeld, R., & Devi, L. A. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.11.008 · Cited by 134
Wersinger, S. R., Caldwell, H. K., Christiansen, M., & Young, W. S. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00294.x · Cited by 134
Regulation of Na+ channels in the cortical collecting duct by AVP and mineralocorticoids
Schafer, J. A., & Hawk, C. T. (1992) · Kidney International · doi:10.1038/ki.1992.37 · Cited by 133
Nonoguchi, H., Owada, A., Kobayashi, N., Takayama, M., Terada, Y., Koike, J., Ujiie, K., Marumo, F., Sakai, T., & Tomita, K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118222 · Cited by 132
Self-citationVasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension?
Bankir, L., Bichet, D. G., & Bouby, N. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00413.2010 · Cited by 131
Vasopressin-V2 Receptor Stimulation Reduces Sodium Excretion in Healthy Humans
Bankir, L., Fernandes, S., Bardoux, P., Bouby, N., & Bichet, D. G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004121079 · Cited by 131
Bosch, O. J., Pförtsch, J., Beiderbeck, D. I., Landgraf, R., & Neumann, I. D. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.01984.x · Cited by 130
Convulsive and hypothermic effects of vasopressin in the brain of the rat
Kasting, N. W., Veale, W. L., & Cooper, K. (1980) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y80-054 · Cited by 130
Maurel, D., Kniazeff, J., Mathis, G., Trinquet, E., Pin, J., & Ansanay, H. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.02.013 · Cited by 130
Association of vasopressin 1a receptor levels with a regulatory microsatellite and behavior
Hammock, E. A. D., Lim, M. M., Nair, H. P., & Young, L. J. (2005) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2005.00119.x · Cited by 130
THE PHYSIOLOGICAL EFFECTS OF EXTRACTS OF THE HYPOPHYSIS CEREBRI AND INFUNDIBULAR BODY
Howell, W. H. (1898) · The Journal of Experimental Medicine · doi:10.1084/jem.3.2.245 · Cited by 130
Wagner, H. N., & D, E. B. M. (1956) · Journal of Clinical Investigation · doi:10.1172/jci103398 · Cited by 129
Koch, M., & Bubser, M. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00576.x · Cited by 128
A serine cluster prevents recycling of the V2 vasopressin receptor
Innamorati, G., Sadeghi, H. M., Tran, N. T., & Birnbaumer, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2222 · Cited by 127
Guillon, G., Trueba, M., BRESSION, D., Grazzini, E., Chouinard, L. A., Côté, M., PAYET, M. D., Manzoni, O. J., Barberis, C., & Robert, M. (1995) · Endocrinology · doi:10.1210/endo.136.3.7867583 · Cited by 127
Thrasher, T. N. (1994) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1994.1007 · Cited by 126
Clinical review: Vasopressin and terlipressin in septic shock patients.
Delmas, A., Léone, M., Rousseau, S., Albanèse, J., & Martin, C. (2004) · Critical Care · doi:10.1186/cc2945 · Cited by 125
Agonist selectivity in the oxytocin/vasopressin receptor family: new insights and challenges
Chini, B., & Manning, M. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350737 · Cited by 123
Åkerlund, M., Bossmar, T., Brouard, R., Kostrzewska, A., Laudanski, T., Lemancewicz, A., Gal, C. S., & Steinwall, M. (1999) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1999.tb08112.x · Cited by 123
Cited by
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Dumais, K. M., & Veenema, A. H. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.04.003 · Cited by 520
“Upon its central release, VP can modulate the activation of many brain regions via binding to vasopressin receptors (discussed further in section 3.a.), thereby regulating social, emotional, and cognitive behaviors (Veenema & Neumann, 2008; Koshimizu et al., 2012; Albers, 2014).”
BackgroundIntranasal oxytocin treatment for social deficits and biomarkers of response in children with autism
Parker, K. J., Oztan, O., Libove, R. A., Sumiyoshi, R. D., Jackson, L. P., Karhson, D. S., Summers, J. E., Hinman, K. E., Motonaga, K. S., Phillips, J. M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705521114 · Cited by 349
Role of neuropeptides in anxiety, stress, and depression: From animals to humans
Kormos, V., & Gaszner, B. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.014 · Cited by 329
Song, Z., & Albers, H. E. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.10.004 · Cited by 244
“Because OTRs, V1aRs, V1bRs, and V2Rs are found on peripheral tissues of virtually every major physiological system of the body, the impact of these peptides is likely to be very widespread [2; 20].”
Background
Metadata
- Authors
- Koshimizu, T.-A., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A.
- Venue
- Physiological Reviews
- Publisher
- American Physiological Society
- Published
- 2012-10
- Volume
- 92
- Issue
- 4
- Pages
- 1813-1864
- ISSN
- 0031-9333 (ISSN-L)
- 1522-1210
- OpenAlex
- W2129819610
- Cited by
- 407
- References
- 515
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.